Inventor
Yuhong Ning
Inventor
San Diego, CA, US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds25%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
PatentTitleYear
9,795,607'Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith'20179,555,033'Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitors'20179,428,509'Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith'20169,346,812'Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2017Patents assigned to SIGNAL PHARM LLC (4)· patent assignee history
2016–2017Patents assigned to SIGNAL PHARMACEUTICAL LLC (3)· patent assignee history
2016–2017Based in San Diego, CA, US· patent location history
2017Patents assigned to CHOPRA RAJESH (1)· patent assignee history
2017Patents assigned to NING YUHONG (1)· patent assignee history
2017Patents assigned to SANKAR SABITA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGNAL PHARM LLC | 4 | 2016–2017 |
| SIGNAL PHARMACEUTICAL LLC | 3 | 2016–2017 |
| CHOPRA RAJESH | 1 | 2017 |
| NING YUHONGself | 1 | 2017 |
| SANKAR SABITA | 1 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 4 | 2016–2017 |